Recent Articles

May 12, 2015 4:18 pm
Ryan Bushey, Associate Editor
Doctors typically implement a CA-125 blood test to detect ovarian cancer because high levels of the protein cause tumors to form. Read more...
May 11, 2015 3:24 pm
Cynthia Fox, Science Editor
In the spirit of its title, this year’s Tribeca Film Festival’s Disruptive Technologies awards ceremony did not distinguish between work that was only simple or complex; only big or small. It focused on work that angled to disrupt the norm, or “transcend limits,” said presenter and Tribeca Film Institute co-founder Craig Hatkoff. Read more...
May 11, 2015 1:44 pm
Ryan Bushey, Associate Editor
The injection is being evaluated as a possible preventative intervention. Read more...
May 11, 2015 10:47 am
Ryan Bushey, Associate Editor
Glaxo will spend a total of $20 million over the next five years to fund this endeavor.  Read more...
May 8, 2015 4:28 pm
Michael Morgen, Ph.D., Bend Research Inc., a division of Capsugel Dosage Form Solutions
In recent years nanotechnology has received significant interest for a wide range of applications, including those within the pharmaceutical industry.  In this area in particular, a number of diverse nano-sized structures have been investigated for drug formulation and delivery. Read more...
May 7, 2015 3:39 pm
Cynthia Fox, Science Editor
The World Health Organization (WHO) announced what many feel is a strong, long-overdue statement condemning parties who do not report results of clinical trials in a timely way. By one account, more than 30 percent of industry and academic groups in the U.S. have not reported results of their clinical trials for 60 months, plus. The WHO outlined specific, and strict, solutions. Read more...
May 7, 2015 9:30 am
Tim Moran, director of life science research at BIOVIA
As organizations in the pharmaceutical and biopharmaceutical space shift their focus from small molecules to protein-based therapies, they can no longer rely on traditional research approaches. Read more...
May 6, 2015 4:20 pm
Ryan Bushey, Associate Editor
The Bill and Melinda Gates Foundation was one of the primary investors this round. Read more...
May 6, 2015 11:17 am
Seth Augenstein, Digital Reporter
​Stem cells can be safely infused to the brain through the carotid artery after a stroke, according to new research presented by a group of doctors and researchers. Read more...
May 5, 2015 11:11 am
Stephanie Guzowski, Editor
Bristol-Myers Squibb is trying its hand at its own combination of drugs — daclatasvir, asunaprevir, and beclabuvir. A 12-week dose of the investigational three-drug hepatitis C combination cleared the virus in 93 percent with liver cirrhosis who hadn’t previously been treated, finds a study, published today in The Journal of the American Medical Association (JAMA). Read more...
Subscribe to Drug Discovery & Development